Vancomycin
Vancomycin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Multiple Sclerosis。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
8 项
已进入 III/IV 期
18 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Icahn School of Medicine at Mount Sinai
- University of Minnesota
- Duke University
- Chuncheon Sacred Heart Hospital
- The Methodist Hospital Research Institute
- Centre of Postgraduate Medical Education
- Hospices Civils de Lyon
- Mahidol University
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
- Xellia Pharmaceuticals USA LLC
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、South Korea、Poland、法国、Thailand、瑞士、瑞典、比利时、Croatia、Czechia、Greece、Israel
正在招募患者的 Vancomycin 研究
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
II 期招募中美国NCT06747611Intestinal Microbiome Transplant in ALS
I 期 / II 期招募中美国NCT07017946Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract
不适用招募中South KoreaNCT06001333Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty
IV 期招募中美国NCT06384651Infection Prevention After TKA With or Without Vancomycin
不适用招募中PolandNCT05461651Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients
I 期 / II 期招募中法国NCT06306014Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane
不适用招募中ThailandNCT06543940Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
II 期招募中美国NCT06428448Irrisept Solution for Instrumented Spine Surgery
不适用招募中美国NCT06439953Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection
不适用招募中美国NCT06293352Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence
III 期招募中瑞士NCT05266807The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
IV 期招募中美国NCT07556107Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
I 期招募中美国NCT07478848Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)
I 期 / II 期招募中美国NCT06640491Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.
II 期招募中瑞典NCT05169229A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis
III 期招募中比利时CroatiaCzechiaGreeceNCT06443502A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
IV 期招募中美国NCT06954129Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
不适用招募中比利时NCT06426836Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
IV 期招募中美国NCT05421741Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
I 期招募中美国NCT02137668Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
IV 期招募中澳大利亚加拿大新西兰NCT06637332Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
不适用招募中中国NCT07204522Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
IV 期招募中澳大利亚NCT05770622Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
不适用招募中美国NCT05055830
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。